Precision Biomedical Laboratory, Liaocheng People's Hospital, Liaocheng, China.
Office of Academic Research, Liaocheng People's Hospital, Liaocheng, China.
Immunol Invest. 2023 Nov;52(7):925-939. doi: 10.1080/08820139.2023.2256778. Epub 2023 Sep 21.
Acute lung injury (ALI) is a common lung disease with increasing morbidity and mortality rates due to the lack of specific drugs. Impaired alveolar fluid clearance (AFC) is a primary pathological feature of ALI. Epithelial sodium channel (ENaC) is a primary determinant in regulating the transport of Na and the clearance of alveolar edema fluid. Therefore, ENaC is an important target for the development of drugs for ALI therapy. However, the role of ENaC in the progression of ALI remains unclear. Inhibition of early growth response factor (EGR-1) expression has been reported to induce a protective effect on ALI; therefore, we evaluated whether EGR-1 participates in the progression of ALI by regulating ENaC-α in alveolar epithelium. We investigated the potential mechanism of EGR-1-mediated regulation of ENaC in ALI. We investigated whether EGR-1 aggravates the pulmonary edema response in ALI by regulating ENaC. ALI mouse models were established by intrabronchial injection of lipopolysaccharides (LPS). Lentiviruses with EGR-1 knockdown were transfected into LPS-stimulated A549 cells. We found that EGR-1 expression was upregulated in the lung tissues of ALI mice and in LPS-induced A549 cells, and was negatively correlated with ENaC-α expression. Knockdown of EGR-1 increased ENaC-α expression and relieved cellular edema in ALI. Moreover, EGR-1 regulated ENaC-α expression at the transcriptional level, and correspondingly promoted pulmonary edema and aggravated ALI symptoms. In conclusion, our study demonstrated that EGR-1 could promote pulmonary edema by downregulating ENaC-α at the transcriptional level in ALI. Our study provides a new potential therapeutic strategy for treatment of ALI.
急性肺损伤(ALI)是一种常见的肺部疾病,由于缺乏特异性药物,其发病率和死亡率不断上升。肺泡液体清除(AFC)受损是 ALI 的主要病理特征。上皮钠离子通道(ENaC)是调节 Na 转运和肺泡水肿液清除的主要决定因素。因此,ENaC 是开发 ALI 治疗药物的重要靶点。然而,ENaC 在 ALI 进展中的作用尚不清楚。据报道,抑制早期生长反应因子(EGR-1)的表达可诱导对 ALI 的保护作用;因此,我们评估了 EGR-1 是否通过调节肺泡上皮细胞中的 ENaC-α参与 ALI 的进展。我们研究了 EGR-1 介导的 ENaC 调节在 ALI 中的潜在机制。我们研究了 EGR-1 是否通过调节 ENaC 加重 ALI 中的肺水肿反应。通过支气管内注射脂多糖(LPS)建立 ALI 小鼠模型。用 EGR-1 敲低的慢病毒转染 LPS 刺激的 A549 细胞。我们发现,EGR-1 在 ALI 小鼠的肺组织和 LPS 诱导的 A549 细胞中表达上调,并且与 ENaC-α表达呈负相关。EGR-1 敲低增加了 ENaC-α的表达,缓解了 ALI 中的细胞水肿。此外,EGR-1 在转录水平上调节 ENaC-α的表达,从而促进肺水肿并加重 ALI 症状。总之,我们的研究表明,EGR-1 可以通过下调 ALI 中的 ENaC-α在转录水平上促进肺水肿。我们的研究为 ALI 的治疗提供了一种新的潜在治疗策略。